United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

Published on :

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin® | United Therapeutics Corporation

Published on :

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has launched commercial sales of the innovative Remunity ® Pump for Remodulin ® for patients with pulmonary arterial hypertension (PAH). “We are excited to bring to market the first subcutaneous pump designed specifically for PAH patients,” said Beth Rhodes, Vice President, Global Supply Chain Alliance Management…

Top Life Science Employers in Maryland, 2020

Published on :

The combination of a booming biotech market with an additional surge of hiring by vaccine and diagnostic companies in Maryland has resulted in record-low unemployment and competition for talent at an all-time high.

The Unisphere Opens in Silver Spring to Grow Transplantable Organs with a Net Zero Carbon Footprint

Published on :

Image Credit: www.utunisphere.com October 1, 2018 The Unisphere Opens in Silver Spring to Grow Transplantable Organs with a Net Zero Carbon Footprint On Friday, September 21st United Therapeutics celebrated the [….]